Journal article

Adipokines in diabetes and cardiovascular diseases


Authors listKralisch S, Sommer G, Deckert CM, Linke A, Blüher M, Stumvoll M, Fasshauer M

Publication year2007

Pages161-171

JournalMinerva Endocrinologica

Volume number32

Issue number3

ISSN0391-1977

URLhttps://www.minervamedica.it/en/journals/minerva-endocrinologica/article.php?cod=R07Y2007N03A0161

PublisherEdizioni Minerva Medica


Abstract
Recent studies suggest that adipocyte-secreted factors called adipokines are involved in obesity-associated complications including hyperlipidemia, diabetes mellitus, arterial hypertension, atherosclerosis, and heart failure. Among those, adiponectin is an antidiabetic and antiatherogenic protein, concentrations of which are decreased in obesity-associated metabolic and vascular disorders. In contrast, leptin, tumor necrosis factor a, interleukin-6, monocyte chemoattractant protein-1, and plasminogen activator inhibitor-1 are upregulated in obesity and contribute to the development of diabetes and vascular disease. In this review, the relevance of adipokines in obesity, insulin resistance, diabetes mellitus, atherosclerosis, and cardiovascular diseases is discussed.



Citation Styles

Harvard Citation styleKralisch S, S. (2007) Adipokines in diabetes and cardiovascular diseases, Minerva Endocrinologica, 32(3), pp. 161-171. https://www.minervamedica.it/en/journals/minerva-endocrinologica/article.php?cod=R07Y2007N03A0161

APA Citation styleKralisch S, S. (2007). Adipokines in diabetes and cardiovascular diseases. Minerva Endocrinologica. 32(3), 161-171. https://www.minervamedica.it/en/journals/minerva-endocrinologica/article.php?cod=R07Y2007N03A0161


Last updated on 2025-21-05 at 16:23